Back
Biogen Quote, Financials, Valuation and Earnings
Sponsored
BIIB
Sponsored
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
28
BIIB
Biogen
Last Price:
157.84
Seasonality Move:
12.81%
7 Day Trial
ALL ACCESS PASS
$
7
Trade on Tuesday. Profit on Friday. Rinse & Repeat
Get the full details now.Biogen Price Quote
$157.84
-0.06 (-0.11%)
(Updated: November 23, 2024 at 3:51 AM ET)
Biogen Key Stats
Sell
28
Biogen (BIIB)
is a Sell
Day range:
$157.28 - $159.72
52-week range:
$153.62 - $268.30
Dividend yield:
0%
P/E ratio:
19.81
P/S ratio:
2.40
P/B ratio:
1.41%
Volume:
1.7M
Avg. volume:
1.6M
1-year change:
-31.72%
Market cap:
$23B
Revenue:
$9.8B
EPS:
$11.07
How Much Does Biogen Make?
Is Biogen Growing As A Company?
Biogen Stock Price Performance
What Is Biogen 52-Week High & Low?
Biogen Price To Free Cash Flow
-
Is Biogen Stock Overvalued?
Biogen is trading at a price to free cash flow ratio of 13.03 -
Is Biogen Stock Undervalued?
Biogen EV to Free Cash Flow ratio is 15.61 -
What Is Biogen’s Price Earnings Growth Ratio?
BIIB PEG ratio is 1.42 -
Is Biogen Trading At A Premium To Earnings?
Biogen EV to EBIT ratio is 12.73
Is It Risky To Buy Biogen?
Is Biogen Cash Flow Positive?
Biogen Return On Invested Capital
Biogen Earnings Date & Stock Price
-
What Is Biogen's Stock Price Today?
A single share of BIIB can be purchased today for 157.90 -
What Is Biogen’s Stock Symbol?
Biogen trades on the S&P500 under the ticker symbol: BIIB -
When Is Biogen’s Next Earnings Date?
The next quarterly earnings date for Biogen is scheduled on February 13, 2025 -
When Is BIIB's next ex-dividend date?
Biogen's next ex-dividend date is June 18, 2020 -
How To Buy Biogen Stock?
You can buy Biogen shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Biogen Competitors
Biogen Dividend Yield
Biogen Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 7.79% |
Revenue: | -2.55% | 1.28% |
Analyst Recommendations
Buy Recommendations: | 15 |
---|---|
Hold Recommendations: | 14 |
Sell Recommendations: | 0 |
Price Target: | 251.70 |
Upside from Last Price: | 59.4% |